<\/p>\n
NEW FILINGS<\/strong><\/p>\n Company: Decibel Therapeutics, Inc. Company: Talis Biomedical Corporation Company: AFC Gamma, Inc. Terms Added<\/strong><\/span><\/p>\n Company: Landos Biopharma, Inc. Company: Sana Biotechnology, Inc. Company: loan Depot, Inc. Company: On24 Inc Company: Atotech Limited Company: Telus International (Cda), Inc. Company: Evaxion Biotech A\/S
\nSymbol: DBTX
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: They are a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders, one of the largest areas of unmet need in medicine.
\nUnderwriter(s): Citigroup, SVB Leerink, BMO Capital Markets, Barclays
\nFiled: 1-22-21
\nListed Cash Raise: $75m<\/p>\n
\nSymbol: TLIS
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: Talis aims to transform diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases and other conditions at the point-of-care.
\nUnderwriter(s): JP Morgan, BofA Securities, Piper Sandler
\nCo-Manager: BTIG
\nFiled: 1-22-21
\nListed Cash Raise: $150m<\/p>\n
\nSymbol: AFCG
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nDescription: AFC Gamma, Inc. is a commercial real estate finance company founded in July 2020 by a veteran team of investment professionals.
\nUnderwriter(s): JMP Securities, Ladenburg Thalmann, Seaport Global
\nCo-Manager: Lake Street
\nFiled: 1-22-21
\nListed Cash Raise: $115m<\/p>\n
\nSymbol: LABP
\nShares: 6.25 million
\nPrice Range: $15.00-$17.00
\nMarket Cap: $588m-$$666m
\nTrade Date: Thursday, 2\/4
\nDescription: They are a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases that are the first to target new mechanisms of action, including the LANCL2, NLRX1 and PLXDC2 immunometabolic pathways.according to the CIC report.
\nUnderwriter(s): JP Morgan, Jefferies, SVB Leerink
\nCo-Manager(s): Raymond James
\nTerms Added: 1-28-21<\/p>\n
\nSymbol: SANA
\nShares: 15 million
\nPrice Range: $20.00-$23.00
\nMarket Cap: $3.5b-$4.03b
\nTrade Date: Thursday, 2\/4
\nDescription: They have long-term aspirations are to be able to control or modify any gene in the body, to replace any cell that is damaged or missing, and to markedly improve access to cellular and gene-based medicines.
\nUnderwriter(s): Morgan Stanley, Goldman Sachs, J.P. Morgan, BofA Securities
\nTerms Added: 1-28-21<\/p>\n
\nSymbol: LDI
\nShares: 15 million
\nPrice Range: $19.00-$21.00
\nMarket Cap: $6.2b-$6.8b
\nTrade Date: Thursday, 2\/4
\nDescription: LoanDepot is a leading technology-enabled U.S. consumer lending platform.
\nUnderwriter(s): Goldman Sachs, BofA Securities, Credit Suisse, Morgan Stanley, Barclays, Citigroup, Jefferies, UBS Investment Bank
\nCo-Manager(s): JMP Securities, Nomura, Piper Sandler, Raymond James, William Blair
\nFiled: 1-27-21<\/p>\n
\nSymbol: ONTF
\nShares: 8.6 million
\nPrice Range: $45.00-$50.00
\nMarket Cap: $2.0b-$2.22b
\nTrade Date: Wednesday, 2\/3
\nDescription: They provide a leading, cloud-based digital experience platform that enables businesses to convert customer engagement into revenue through interactive webinar experiences, virtual event experiences and multimedia content experiences.
\nUnderwriter(s): Goldman Sachs, JP Morgan, KeyBanc Capital
\nTerms Added: 1-25-21<\/p>\n
\nSymbol: ATC
\nDescription: They are the leading global provider of specialty electroplating solutions delivering chemistry, equipment, and service for high-growth technology applications.
\nShares: 34.1 million
\nPrice Range: $19.00-$22.00
\nMarket Cap: $3.5b-$4.0b
\nTrade Date: Thursday 2\/4
\nUnderwriter(s): Citigroup, Credit Suisse, BofA Securities, JP Morgan
\nBarclays, Deutsche Bank, Jefferies, RBC Capital Markets, UBS Investment Bank, Baird, BMO Capital Markets, HSBC
\nCo-Manager(s): TPG Capital, Mischler Financial Group
\nTerms Added: 1-25-21<\/p>\n
\nSymbol: TIXT
\nShares: 33.3 million
\nPrice Range: $23.00-$25.00
\nMarket Cap: $6.1b-$6.7b
\nTrade Date: Wednesday, 2\/3
\nDescription: They are a leading digital customer experience innovator that designs, builds and delivers next-generation solutions for global and disruptive brands.
\nUnderwriter(s): JP Morgan, Morgan Stanley, Barclays, BofA Securities, CIBC Capital, Citigroup, Credit Suisse, RBC Capital, Baird, BMO Capital
\nCo-Manager(s): Scotiabank, TD, Wells Fargo, William Blair, MUFG, National Bank of Canada Financial Markets
\nTerms Added: 1-25-21<\/p>\n
\nSymbol: EVAX
\nShares: 2.75 million
\nPrice Range: $10.00-$12.00
\nMarket Cap: $190m-$227m
\nTrade Date: Thursday, 2\/4
\nDescription: They are a clinical-stage AI-immunology\u2122 platform company using our propri
\netary artificial intelligence, or AI, technology, engineering expertise and drug development know-how to simulate the human immune system and generate predictive models to identify and develop novel immunotherapies for the treatment of various cancers, bacterial diseases and viral infections.
\nUnderwriter(s): Oppenheimer
\nCo-Manager: Ladenburg Thalmann
\nTerms Added: 1-25-21<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":12986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[2058,1536],"tags":[],"class_list":["post-17147","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-spotlight","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/17147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=17147"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/17147\/revisions"}],"predecessor-version":[{"id":17148,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/17147\/revisions\/17148"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/12986"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=17147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=17147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=17147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}